Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Draegerwerk AG KGaADGWPF 70 EV-to-EBIT is 6.83 as of Aug. 13, 2026, which is 12% above its 10-year median of 6.09. GuruFocus rates DGWPF with a GF Score™ of 70/100 and a GF Value™ of $61.02 (Significantly Overvalued). The stock has 4 warning signs investors should review. Among 471 Medical Devices & Instruments companies, Draegerwerk AG KGaA ranks better than 88.54% on this metric.
Draegerwerk AG KGaA (OTCPK:DGWPF) EV-to-EBIT Explanation
This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.
Draegerwerk AG KGaA's Enterprise Value for the quarter that ended in Jun. 2026 was $1,749 Mil.
Draegerwerk AG KGaA's EBIT for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $336 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Draegerwerk AG KGaA EV-to-EBIT Related Terms
Draegerwerk AG KGaA EV-to-EBIT Historical Data
* Premium members only.
The historical data trend for Draegerwerk AG KGaA's EV-to-EBIT can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Draegerwerk AG KGaA's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Draegerwerk AG KGaA EV-to-EBIT vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Draegerwerk AG KGaA's EV-to-EBIT distribution charts can be found below:
* The bar in red indicates where Draegerwerk AG KGaA's EV-to-EBIT falls into.
Draegerwerk AG KGaA's current Enterprise Value is $2,297 Mil.
Draegerwerk AG KGaA's EBIT for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $336 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Draegerwerk AG KGaA (DGWPF) has a EV-to-EBIT of 6.83 as of Aug. 13, 2026. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Draegerwerk AG KGaA and its competitors. This is 12% above median its historical median of 6.09. According to the industry distribution chart, Draegerwerk AG KGaA ranks #54 out of 471 companies in the Medical Devices & Instruments industry, placing it in the top 11.5%.
Is Draegerwerk AG KGaA's EV-to-EBIT too high?
Draegerwerk AG KGaA's current EV-to-EBIT of 6.83 is 12% above median its 10-year median of 6.09. The Medical Devices & Instruments industry median EV-to-EBIT is 19.17. Draegerwerk AG KGaA's value of 6.83 is 64.4% below this industry median. Based on the distribution chart, Draegerwerk AG KGaA ranks #54 out of 471 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Draegerwerk AG KGaA has a GF Score™ of 70/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Draegerwerk AG KGaA's EV-to-EBIT compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Draegerwerk AG KGaA ranks #54 out of 471 companies for EV-to-EBIT. This places Draegerwerk AG KGaA in the top 12% of its industry — outperforming the majority of peers. The industry median EV-to-EBIT is 19.17. Draegerwerk AG KGaA's value of 6.83 is 64.4% below this benchmark. While the company's 10-year median is 6.09 vs. the industry median of 19.17, Draegerwerk AG KGaA has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBIT for a Medical Devices & Instruments company?
The median EV-to-EBIT among Medical Devices & Instruments companies is 19.17, based on 471 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBIT significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Draegerwerk AG KGaA's current EV-to-EBIT of 6.83 is 64.4% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBIT mean?
A high EV-to-EBIT can signal that a stock is expensive relative to its fundamentals. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Draegerwerk AG KGaA and its competitors. For the Medical Devices & Instruments industry, the median EV-to-EBIT is 19.17 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Draegerwerk AG KGaA's current EV-to-EBIT is 6.83, which is 12% above median its own 10-year median of 6.09. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Draegerwerk AG KGaA stock overvalued right now?
Based on GuruFocus' analysis, Draegerwerk AG KGaA (DGWPF) is currently considered Significantly Overvalued. The stock's GF Value™ is $61.02, compared to a current price of $93.00 — trading 52.4% above its estimated fair value. The current EV-to-EBIT is 6.83, which is 12% above median its 10-year median of 6.09 and 64.4% below the Medical Devices & Instruments industry median of 19.17. Draegerwerk AG KGaA's overall GF Score™ is 70/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBIT calculated?
EV-to-EBIT is calculated from a company's financial statements. For Draegerwerk AG KGaA (DGWPF), the current EV-to-EBIT is 6.83 as of Aug. 13, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Draegerwerk AG KGaA (DGWPF) Overvalued in 2026?
Based on GuruFocus' analysis, Draegerwerk AG KGaA stock appears to be overvalued.
The current stock price of $93.00 is trading 52.4% above its estimated GF Value™ of $61.02.
GuruFocus considers Draegerwerk AG KGaA to be Significantly Overvalued.
Key valuation signals for DGWPF:
EV-to-EBIT: 6.83 (12% above median its 10-year median of 6.09)
GF Value™: $61.02 vs. price of $93.00 (52.4% above fair value)
Industry Position: 64.4% below the Medical Devices & Instruments median (#54 of 471)
No single metric tells the full story. See the DGWPF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Draegerwerk AG & Co KGaA develops medical and safety equipment for clinical and industrial applications. The firm operates in two segments: medical and safety. The medical division contributes the majority of revenue, it develops and produces system solutions, equipment, and services for the acute point of care, it has five business units Therapy, Hospital Consumables & Accessories, Workplace Infrastructure, Monitoring, and Data Business. Its safety division develops and produces devices, system solutions, and services for personal protection, gas detection, and integrated hazard management. Its geographical segments are Europe; Germany; the Americas; Africa, Asia, and Australia.
70GF Score
Get the complete analysis for DGWPF
EV-to-EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
DGWPF has been successfully added to your 
